Kidney Stones May Increase Fracture Risk

This article originally appeared here.
Share this content:
Kidney Stones May Increase Fracture Risk
Kidney Stones May Increase Fracture Risk

(HealthDay News) -- Urolithiasis patients may be at increased risk for fractures and may require treatment to protect their bone health, according to a new study published online Oct. 23 in the Clinical Journal of the American Society of Nephrology.

Researchers led by Michelle Denburg, M.D., of the Children's Hospital of Philadelphia, analyzed data from 51,785 British urolithiasis patients and 517,267 people without urolithiasis.

During a median follow-up of nearly five years, urolithiasis patients were found to be at significantly higher risk for fractures, and this increased risk affected all bones, Denburg's team found. Overall, males with urolithiasis were 10 percent more likely to suffer broken bones than those without urolithiasis. The risk was highest among male teens -- those with urolithiasis had a 55 percent higher risk for fractures than those without the condition. Among women, those with urolithiasis had a 17 to 52 percent increased risk of fractures from their 20s to their 60s, with the highest risk among women aged 30 to 39.

The findings only point to an association between urolithiasis and fracture risk, and do not prove a cause-and-effect relationship. However, the researchers believe that efforts to boost urolithiasis patients' bone health might help shield them from fractures. "Given that the median time from diagnosis of urolithiasis to fracture was a decade, we might be able to intervene during this interval to reduce the burden of future fracture," Denburg said in a news release from the American Society of Nephrology.

Full Article
Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »